Effect of interferon-alpha A/D in combination with the Japanese and Chinese traditional herbal medicine juzen-taiho-to on lung metastasis of murine renal cell carcinoma
- PMID: 11062703
Effect of interferon-alpha A/D in combination with the Japanese and Chinese traditional herbal medicine juzen-taiho-to on lung metastasis of murine renal cell carcinoma
Abstract
Several studies have shown that the Kampo medicine Juzen-taiho-to (Si-Quan-Da-Bu-Tang in Chinese) has various biological activities, including anti-tumor effects when combined with surgical excision or with chemotherapeutic drugs. Here we investigated the effect of combined therapy with interferon (IFN)-alpha A/D and Juzen-taiho-to on experimental lung metastasis of murine renal cell carcinoma (Renca) cells. Five consecutive administrations of IFN-alpha A/D to Renca-bearing mice resulted in dose-dependent inhibition of lung metastasis. IFN-alpha A/D at the dose of 100,000 IU/mouse significantly inhibited the metastasis, but a marked loss of body weight was observed during and after the administration. In contrast, oral administration of Juzen-taiho-to (50 mg/mouse) alone tended to inhibit the metastasis, but the effect was not statistically significant. The combination treatment of suboptimal doses of IFN-alpha A/D and Juzen-taiho-to markedly augmented the antimetastatic effect without causing any loss of body weight, as compared with either treatment alone. Similar results were also obtained by treatment with IFN-gamma in combination with Juzen-taiho-to. Clinically, immunotherapy with IFNs has been primarily approved for the treatment of patients with metastatic renal cell carcinoma, but sufficient efficacy has not yet been obtained. Therefore, the combination of IFNs with Juzen-taiho-to may provide a means to increase the therapeutic potential of IFNs and to decrease their toxicity for the treatment of metastatic renal cell carcinoma.
Similar articles
-
Antitumor effects of alpha-interferon and gamma-interferon on a murine renal cancer (Renca) in vitro and in vivo.Cancer Res. 1990 Sep 1;50(17):5414-20. Cancer Res. 1990. PMID: 2117482
-
Synergistic in vivo antitumor effect of the histone deacetylase inhibitor MS-275 in combination with interleukin 2 in a murine model of renal cell carcinoma.Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4538-46. doi: 10.1158/1078-0432.CCR-07-0014. Clin Cancer Res. 2007. PMID: 17671140
-
Expression of the anti-metastatic effect induced by Juzen-taiho-to is based on the content of Shimotsu-to constituents.Biol Pharm Bull. 1998 Jul;21(7):761-5. doi: 10.1248/bpb.21.761. Biol Pharm Bull. 1998. PMID: 9703264
-
Interferon in metastatic renal cell carcinoma.Semin Oncol. 2000 Apr;27(2):187-93. Semin Oncol. 2000. PMID: 10768597 Review.
-
Retinoids and metastatic renal cell carcinoma.Ann Med Interne (Paris). 1997;148(7):496-501. Ann Med Interne (Paris). 1997. PMID: 9538388 Review.
Cited by
-
The translational aspect of complementary and alternative medicine for cancer with particular emphasis on Kampo.Front Pharmacol. 2015 Aug 6;6:150. doi: 10.3389/fphar.2015.00150. eCollection 2015. Front Pharmacol. 2015. PMID: 26300773 Free PMC article. Review.
-
Role of Kampo medicine in integrative cancer therapy.Evid Based Complement Alternat Med. 2013;2013:570848. doi: 10.1155/2013/570848. Epub 2013 Aug 22. Evid Based Complement Alternat Med. 2013. PMID: 23997796 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical